HI
OGEN icon

Harbour Investments’s Oragenics OGEN Stock Holding History

Harbour Investments’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19 Hold
34
– – ﹤0.01% 4625
2025
Q4 		$27 Hold
34
– – ﹤0.01% 3817
2025
Q3 		$45 Hold
34
– – ﹤0.01% 3681
2025
Q2 		$130 Buy
+34
New +$172 ﹤0.01% 3503

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $238M AUM 22.04% 1-Year Est. Return

Harbour Investments's OGEN Position: Q1 2026 in Review

Harbour Investments held its Oragenics (OGEN) position steady in Q1 2026 at 34 shares worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #4625.

Harbour Investments first reported a position in OGEN in Q2 2025 and has held it in 4 quarters since. The position peaked at $130 in Q2 2025. 19 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.

  • Harbour Investments held 34 shares of Oragenics worth $19 as of Q1 2026.
  • Harbour Investments left its Oragenics share count unchanged in Q1 2026.
  • Oragenics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4625 holding.
  • Harbour Investments first reported a position in Oragenics in Q2 2025 and has held it in 4 quarters since.
  • Harbour Investments's Oragenics position peaked at $130 in Q2 2025.
  • 19 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.